Statistics

Total Visits

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)63

Select a period of time:

Number of views in the range

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)31

Views

Views
June 20252
July 202522
August 20251
September 20253
October 20252
November 20251
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Brazil11
United Kingdom4
Colombia1
Costa Rica1
Morocco1
Mexico1
Peru1
 

Top cities views

Views
Dallas2
Abancay1
Albertville1
Apucarana1
Baltimore1
Barueri1
Bolton1
Callahan1
Carapicuíba1
Covington1